| Plasma concentration of von Willebrand factor predicts mortality in patients on chronic renal replacement therapy. | |
| | |
MedLine Citation:
|
PMID: 22189209 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
BACKGROUND: Traditional cardiovascular risk factors do not explain the high incidence of cardiovascular mortality and morbidity in patients with end-stage renal disease. A prothrombotic state could accelerate the process of vascular disease in these patients.METHODS: In this study, four platelet activation markers (NAP-2, P-selectin, GP1b and RANTES) and two endothelial cell activation markers (von Willebrand factor and its propeptide) were measured in 671 haemodialysis patients and 275 patients on continuous ambulatory peritoneal dialysis (PD). All were long-term dialysis patients. The risk of all-cause and cardiovascular mortality was assessed in relation to these markers after a mean follow-up time of 2.5 years.RESULTS: The von Willebrand factor showed a positive correlation with total mortality in the haemodialysis patients. In an unadjusted model, the hazard rate (HR) of total mortality was 2.4 [95% confidence interval (95% CI) 1.7-3.4] in the upper quartile of von Willebrand factor compared with the lowest quartile. It remained statistically significant (HR 1.8; 95% CI 1.2-2.6) after adjustment for traditional risk factors. In contrast, no significant correlation was found between von Willebrand factor levels and total mortality in PD patients. Finally, no relationship between platelet activation markers and total mortality was found in either the haemodialysis or the PD patients.CONCLUSION: It can be concluded that chronic endothelial cell activation, but not platelet activation, is related to all-cause mortality in end-stage renal disease patients on long-term dialysis. |
| | |
Authors:
|
Nathalie C Péquériaux; Rob Fijnheer; Eugenie F Gemen; Arjan D Barendrecht; Friedo W Dekker; Raymond T Krediet; Jaap J Beutler; Elisabeth W Boeschoten; Mark Roest |
Related Documents
:
|
16829779 - An association study between catechol-o-methyl transferase gene polymorphism and metham... 15337649 - Sex differences in functional connectivity in first-episode and chronic schizophrenia p... 17244179 - Anterior cingulate activation in antipsychotic-naïve first-episode schizophrenia. 12167509 - Cost of treating bipolar disorder in the california medicaid (medi-cal) program. 8817739 - Diurnal mood variation in melancholic patients and healthy controls. 8968299 - Clozapine-induced urinary incontinence: incidence and treatment with ephedrine. 10752739 - A biopsy of the use of the baxter formula to resuscitate burns or do we do it like char... 1105129 - Transformation of lymphocytes in patients with certain bacterial infections. 11060869 - Differentiating the ligament of marshall from the pulmonary vein musculature potentials... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-12-20 |
Journal Detail:
|
Title: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association Volume: - ISSN: 1460-2385 ISO Abbreviation: - Publication Date: 2011 Dec |
Date Detail:
|
Created Date: 2011-12-22 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8706402 Medline TA: Nephrol Dial Transplant Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
1Department of Clinical Chemistry and Haematology, Jeroen Bosch Hospital, `s-Hertogenbosch, The Netherlands. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Determination of brachial artery stiffness prior to vascular access creation: reproducibility of pul...
Next Document: A novel, inexpensive and easy to use tendon clamp for in vitro biomechanical testing.